Actionable results in under 2 minutes
Precision with near 1:1 relationship with arterial blood gas
Non-invasive measurements conducted by any qualified medical staff
Today’s frontline clinicians face increasing diagnostic uncertainty when evaluating patients with respiratory distress. Cardiovascular and respiratory abnormalities often overlap with vague symptoms, prompting numerous serial tests to rule out conditions and leading to unnecessary observation admissions.
Built for the rapid evaluation of your patient's cardiorespiratory function, the AGM100® closes critical gaps in the detection of hypoxemic severity and gas exchange abnormality to improve patient safety, support diagnosis and treatment to accelerate healthcare decision making.
Patient Symptoms
Conditions Associated with Respiratory Impairment
Sources
1 https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2828189
2 https://pubmed.ncbi.nlm.nih.gov/34671670/, https://bmjopenrespres.bmj.com/content/11/1/e002250
3 http://dx.doi.org/10.1016/j.chest.2017.02.003
4 https://pubmed.ncbi.nlm.nih.gov/35976533
5 https://pubmed.ncbi.nlm.nih.gov/40869707/
AGM100: PoC Innovation newly reimbursable under dedicated CPT® code with Ambulatory Procedure classification.
Essential Clinical Insights, Non-Invasively Delivered Instantly at the Point-of-Care

Pulmonary gas exchange is critical for our health- as shown in the lungs' tiny alveoli. Here, oxygen is absorbed into the blood, and carbon dioxide is released to be exhaled. This natural process of gas movement in the body, called diffusion, occurs in 500 million alveoli and ensures our blood is oxygen-rich for circulation.
The AGM100 technology leverages this principle, monitoring gas levels directly with advanced sensors combined with computational means to enhance precision to aid in assessing patients' respiratory and cardiovascular health. Vital clinical information, such as blood oxygenation, ventilation and gas exchange, that traditionally required time-consuming invasive procedures is now available at the point-of-care with the AGM100.
Assessing respiratory impairment in patients is a critical aspect of clinical management. Traditionally, the Riley method (A-a gradient) has been the gold standard measure for gas exchange efficiency, but this approach...
Clinicians know that unlike other tests, the AGM100 provides accurate measurements of gas exchange impairment to differentiate healthy and sick patients...
Patients in respiratory distress require immediate medical attention. The ability to quickly identify hypoxemia is crucial...

“Innovative technologies are accelerating access to healthcare everywhere, we must ensure that they (innovative technologies) are readily available in all health facilities, fairly priced and quality-assured...”
DR MARIÂNGELA SIMÃO
WHO Assistant Director General

“The AGM100 is already playing a crucial role in respiratory assessment and treatment in a quickly growing number of hospitals across the nation."
LOS ANGELES BUSINESS JOURNAL

“These winners represent some of the most promising emerging medical device innovations in the diagnosis, treatment, and care of children affected..."
PAUL GRAND
CEO of MedTech Innovator